INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN
The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atroph...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RITTIG, Nikolaj Fibiger SMEDEGAARD, Stine Bech CHRISTENSEN, Britt HULMAN, Adam MOSE, Maike MIKKELSEN, Ulla Ramer LAURIDSEN, Kasper Bøgelund NIELSEN, Søren Bang FREDERIKSEN, Pernille Dorthea MØLLER, Niels MARKHOLM, Mie JÆGER, Tanja Christine |
| description | The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4061399A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4061399A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4061399A13</originalsourceid><addsrcrecordid>eNrjZHDw9AsO9fH08w8J8g_wdFZw9HNRcPcJdXZ094eLubq5uTqHBCv4uyk4uYY46vo4Oof4u_v4O4E08jCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeNcAEwMzQ2NLS0dDYyKUAACHrSqh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN</title><source>esp@cenet</source><creator>RITTIG, Nikolaj Fibiger ; SMEDEGAARD, Stine Bech ; CHRISTENSEN, Britt ; HULMAN, Adam ; MOSE, Maike ; MIKKELSEN, Ulla Ramer ; LAURIDSEN, Kasper Bøgelund ; NIELSEN, Søren Bang ; FREDERIKSEN, Pernille Dorthea ; MØLLER, Niels ; MARKHOLM, Mie ; JÆGER, Tanja Christine</creator><creatorcontrib>RITTIG, Nikolaj Fibiger ; SMEDEGAARD, Stine Bech ; CHRISTENSEN, Britt ; HULMAN, Adam ; MOSE, Maike ; MIKKELSEN, Ulla Ramer ; LAURIDSEN, Kasper Bøgelund ; NIELSEN, Søren Bang ; FREDERIKSEN, Pernille Dorthea ; MØLLER, Niels ; MARKHOLM, Mie ; JÆGER, Tanja Christine</creatorcontrib><description>The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220928&DB=EPODOC&CC=EP&NR=4061399A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220928&DB=EPODOC&CC=EP&NR=4061399A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RITTIG, Nikolaj Fibiger</creatorcontrib><creatorcontrib>SMEDEGAARD, Stine Bech</creatorcontrib><creatorcontrib>CHRISTENSEN, Britt</creatorcontrib><creatorcontrib>HULMAN, Adam</creatorcontrib><creatorcontrib>MOSE, Maike</creatorcontrib><creatorcontrib>MIKKELSEN, Ulla Ramer</creatorcontrib><creatorcontrib>LAURIDSEN, Kasper Bøgelund</creatorcontrib><creatorcontrib>NIELSEN, Søren Bang</creatorcontrib><creatorcontrib>FREDERIKSEN, Pernille Dorthea</creatorcontrib><creatorcontrib>MØLLER, Niels</creatorcontrib><creatorcontrib>MARKHOLM, Mie</creatorcontrib><creatorcontrib>JÆGER, Tanja Christine</creatorcontrib><title>INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN</title><description>The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDw9AsO9fH08w8J8g_wdFZw9HNRcPcJdXZ094eLubq5uTqHBCv4uyk4uYY46vo4Oof4u_v4O4E08jCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeNcAEwMzQ2NLS0dDYyKUAACHrSqh</recordid><startdate>20220928</startdate><enddate>20220928</enddate><creator>RITTIG, Nikolaj Fibiger</creator><creator>SMEDEGAARD, Stine Bech</creator><creator>CHRISTENSEN, Britt</creator><creator>HULMAN, Adam</creator><creator>MOSE, Maike</creator><creator>MIKKELSEN, Ulla Ramer</creator><creator>LAURIDSEN, Kasper Bøgelund</creator><creator>NIELSEN, Søren Bang</creator><creator>FREDERIKSEN, Pernille Dorthea</creator><creator>MØLLER, Niels</creator><creator>MARKHOLM, Mie</creator><creator>JÆGER, Tanja Christine</creator><scope>EVB</scope></search><sort><creationdate>20220928</creationdate><title>INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN</title><author>RITTIG, Nikolaj Fibiger ; SMEDEGAARD, Stine Bech ; CHRISTENSEN, Britt ; HULMAN, Adam ; MOSE, Maike ; MIKKELSEN, Ulla Ramer ; LAURIDSEN, Kasper Bøgelund ; NIELSEN, Søren Bang ; FREDERIKSEN, Pernille Dorthea ; MØLLER, Niels ; MARKHOLM, Mie ; JÆGER, Tanja Christine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4061399A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RITTIG, Nikolaj Fibiger</creatorcontrib><creatorcontrib>SMEDEGAARD, Stine Bech</creatorcontrib><creatorcontrib>CHRISTENSEN, Britt</creatorcontrib><creatorcontrib>HULMAN, Adam</creatorcontrib><creatorcontrib>MOSE, Maike</creatorcontrib><creatorcontrib>MIKKELSEN, Ulla Ramer</creatorcontrib><creatorcontrib>LAURIDSEN, Kasper Bøgelund</creatorcontrib><creatorcontrib>NIELSEN, Søren Bang</creatorcontrib><creatorcontrib>FREDERIKSEN, Pernille Dorthea</creatorcontrib><creatorcontrib>MØLLER, Niels</creatorcontrib><creatorcontrib>MARKHOLM, Mie</creatorcontrib><creatorcontrib>JÆGER, Tanja Christine</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RITTIG, Nikolaj Fibiger</au><au>SMEDEGAARD, Stine Bech</au><au>CHRISTENSEN, Britt</au><au>HULMAN, Adam</au><au>MOSE, Maike</au><au>MIKKELSEN, Ulla Ramer</au><au>LAURIDSEN, Kasper Bøgelund</au><au>NIELSEN, Søren Bang</au><au>FREDERIKSEN, Pernille Dorthea</au><au>MØLLER, Niels</au><au>MARKHOLM, Mie</au><au>JÆGER, Tanja Christine</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN</title><date>2022-09-28</date><risdate>2022</risdate><abstract>The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4061399A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T11%3A32%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RITTIG,%20Nikolaj%20Fibiger&rft.date=2022-09-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4061399A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |